Miller Mary
SEC CIK 1841088 · EDGAR
BoughtSold
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:09 | 2026-08-18 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | S - Sale | $2.01 | -185 | 82.0K | -0.2% | -$371.85 | |
| 2026-07-23 16:28 | 2026-07-21 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | S - Sale | $1.76 | -573 | 82.2K | -0.7% | -$1,008 | |
| 2026-05-20 16:30 | 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | A - Grant | $0.00 | +49.8K | 82.8K | +151% | $0 | |
| 2026-05-18 16:11 | 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.92 | -184 | 32.9K | -0.6% | -$353.28 | |
| 2026-04-21 17:05 | 2026-04-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.78 | -558 | 33.1K | -2% | -$993.24 | |
| 2026-02-18 | 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.63 | -217 | 33.7K | -0.6% | -$353.71 | |
| 2026-01-21 | 2026-01-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.98 | -659 | 33.9K | -2% | -$1,305 | |
| 2025-11-18 | 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $2.24 | -184 | 34.6K | -0.5% | -$412.16 | |
| 2025-10-21 | 2025-10-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.81 | -558 | 34.7K | -2% | -$1,010 | |
| 2025-10-03 | 2025-10-01 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.81 | -284 | 35.3K | -0.8% | -$514.04 | |
| 2025-08-18 | 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.39 | -184 | 35.6K | -0.5% | -$255.76 | |
| 2025-07-21 | 2025-07-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.32 | -558 | 35.8K | -2% | -$736.56 | |
| 2025-05-16 | 2025-05-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.14 | -184 | 36.3K | -0.5% | -$209.76 | |
| 2025-04-18 | 2025-04-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $1.81 | -558 | 36.5K | -2% | -$1,010 | |
| 2025-02-19 | 2025-02-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $5.42 | -217 | 37.1K | -0.6% | -$1,176 | |
| 2025-01-22 | 2025-01-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $5.78 | -659 | 37.3K | -2% | -$3,809 | |
| 2024-11-18 | 2024-11-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $7.92 | -184 | 37.9K | -0.5% | -$1,457 | |
| 2024-10-21 | 2024-10-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $7.87 | -558 | 38.1K | -1% | -$4,391 | |
| 2024-10-03 | 2024-10-01 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $6.98 | -284 | 38.7K | -0.7% | -$1,982 | |
| 2024-08-16 | 2024-08-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $7.02 | -184 | 39.0K | -0.5% | -$1,292 | |
| 2024-07-19 | 2024-07-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $7.69 | -558 | 39.2K | -1% | -$4,291 | |
| 2024-05-16 | 2024-05-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $8.36 | -184 | 39.7K | -0.5% | -$1,538 | |
| 2024-04-19 | 2024-04-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $10.34 | -558 | 39.9K | -1% | -$5,770 | |
| 2024-02-16 | 2024-02-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $3.40 | -217 | 40.5K | -0.5% | -$737.80 | |
| 2024-01-19 | 2024-01-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $4.35 | -652 | 40.7K | -2% | -$2,836 | |
| 2023-11-16 | 2023-11-14 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $5.08 | -735 | 41.3K | -2% | -$3,734 | |
| 2023-10-19 | 2023-10-17 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | F - Tax | $5.48 | -2,232 | 42.1K | -5% | -$12.2K | |
| D | 2023-09-28 | 2023-09-26 | ACRV | Acrivon Therapeutics, Inc. | Miller Mary | CLO | A - Grant | $0.00 | +3,858 | 44.3K | +10% | $0 |
| 2022-03-24 | 2022-03-22 | BFLY | Butterfly Network, Inc. | Miller Mary | GC, Corp Sec | A - Grant | $0.00 | +54.8K | 383.5K | +17% | $0 | |
| 2022-03-08 | 2022-03-04 | BFLY | Butterfly Network, Inc. | Miller Mary | GC, Corp Sec | A - Grant | $0.00 | +189.7K | 328.7K | +136% | $0 | |
| 2022-02-17 | 2022-02-16 | BFLY | Butterfly Network, Inc. | Miller Mary | GC, Corp Sec | S - Sale | $5.95 | -16.7K | 139.1K | -11% | -$99.2K |
Purchase Sale Sale after option exercise All abbreviations